RE:RE:RE:RE:RE:All this needswoundedknee wrote: Regardless when the kick off begins..this will be the second phase two of the same drug.
Very true Woundedknee - that is absolutely correct.
But ...
This time it's much higher dosing to start with a taper (likely) - for a very short period.
That's why it likely gets a new patent ... method change.
---------------------
Then, consider how this could be used in chronic ... at higher dose ... reduced frequency ... under close watch of a Specialist.
I'm not say it's going to go there - I'm just saying that I see a potential secondary path.
Maybe that path needs a Phase 2 or maybe there's a faster path once we get acute (if we get acute). Don't know - yet.
---------------------
I do predict this pause and recent development work ... puts us further ahead in this space. Lots of work and mucho money to be spent creating a market. IMO.